French pharmaceutical company Sanofi has teamed up with Google’s life sciences team to improve care for people diagnosed with type 1 and type 2 diabetes.
The companies will combine their expertise to work on better ways to collect, analyze and understand multiple sources of information affecting diabetes.
The collaboration will see the combination of Google’s analytics, miniaturised electronics and low power chip design with Sanofi’s diabetes treatments to find out new ways to improve diabetes care.
The companies are planning to introduce new tools that will bring together previously used siloed pieces of diabetes management and enable new kinds of interventions.
Through the collaboration, the companies aim to come up with a solution to help patients successfully manage their diabetes, which would also reduce the risk of complications, improve outcomes and ultimately lower costs.
Google life sciences team CEO Andy Conrad said: "With new technologies emerging to provide a more continuous and real-time view of a patient’s health, we can see the promise for more proactive and effective ways to control diabetes.
"Together with Sanofi, we believe diabetes management can be simpler and more convenient, which may help patients achieve an improved quality of life."